American Renal Associates (ARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 216,127 | 192,955 | 185,567 | 172,131 | 174,211 |
| Cost of Goods | 121,104 | 116,115 | 109,779 | 105,455 | 102,606 |
| Gross Profit | 95,023 | 76,840 | 75,788 | 66,676 | 71,605 |
| Operating Expenses | 53,208 | 46,203 | 43,188 | 29,655 | 30,178 |
| Operating Income | 41,919 | 30,752 | 33,379 | 37,476 | 42,033 |
| Interest Expense | 7,388 | 7,372 | 8,941 | 12,258 | 10,761 |
| Other Income | -3,444 | 12,565 | -12,543 | 0 | 0 |
| Pre-tax Income | 31,087 | 35,945 | 11,895 | 25,218 | 31,272 |
| Income Tax | 1,066 | -101 | -1,147 | 2,661 | 3,552 |
| Net Income Continuous | 30,021 | 36,046 | 13,042 | 22,557 | 27,720 |
| Minority Interests | 33,609 | 23,622 | 22,488 | 18,801 | 20,878 |
| Net Income | $-3,588 | $12,424 | $-9,446 | $3,756 | $6,842 |
| EPS Basic Total Ops | -0.01 | 0.35 | -0.76 | 0.17 | 0.30 |
| EPS Basic Continuous Ops | 0.97 | 1.17 | 0.46 | 1.02 | 1.25 |
| EPS Diluted Total Ops | 0.01 | 0.34 | -0.76 | 0.16 | 0.30 |
| EPS Diluted Continuous Ops | 1.02 | 1.15 | 0.46 | 0.99 | 1.22 |
| EBITDA(a) | $51,328 | $40,064 | $42,641 | $45,950 | $51,774 |